Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
Exercise increases metabolism, allowing you to burn more calories even at rest
It is the acetylated form of L-carnitine (LC)
It inhibits NNMT, an enzyme that methylates nicotinamide (a precursor to NAD+)
Side Effects & Safety Typical first-cycle side effects: Weeks 1-2: mild water retention, vivid dreams, light head/warmth after injection Weeks 3-4: occasional joint stiffness, improved sleep quality, slight appetite increase overnight Weeks 5-8: adaptation phase most side effects fade, body composition changes visible Clinical discontinuation signals (trial-reported): Clinical participants in tesamorelin studies were discontinued upon experiencing: Persistent headaches with visual changes (intracranial pressure marker in trial monitoring protocols) Sustained fasting glucose elevation of ~15 mg/dL above baseline Unusual peripheral swelling persisting beyond weeks 1-2 Carpal tunnel symptoms unresponsive to dose titration in community-reported protocols Tesamorelin has been studied at 2mg/day for 6+ months without notable safety signals at therapeutic doses
It belongs to a class of drugs called GLP-1 receptor agonists, which help regulate blood sugar levels and promote weight loss by mimicking the hormone GLP-1
References ESMO Patient Guide on Immunotherapy Side Effects
US$ 27.82
US$ 28.26
US$ 29.02
US$ 26.59
US$ 21.79
